DossierENTITY

Dr. Brian Wolpin

Coverage of Dr. Brian Wolpin in the Nexus archive.

Earliest in view: May 31 · 12:05 UTCMost recent: May 31 · 12:05 UTC

Co-mentioned in this coverage

daraxonrasibtopic1 pancreatic cancertopic1 University of California, Los Angelesorganization1 University of Arizona Cancer Centerorganization1 Dana-Farber Cancer Instituteorganization1 Revolution Medicinesorganization1 Food and Drug Administrationorganization1 New England Journal of Medicineorganization1 American Society for Clinical Oncologyorganization1 Dr. Zev Wainbergperson1 Dr. Rachna Shroffperson1 Ben Sasseperson1

Recent coverage

HEALTHMay 31 · 12:05 UTCWPLG LOCAL 10 MIAMI
Experimental pill promises new hope for deadly pancreatic cancer
A new experimental pill, daraxonrasib, nearly doubled survival time for patients with advanced pancreatic cancer compared to chemotherapy, with fewer severe side effects. The drug, which targets a mutated protein common in pancreatic cancer, is being fast-tracked for FDA review and has shown improved quality of life for patients.